BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Research

Novotech Acquires European CRO, Strengthens Global Operations

The acquisition means biotech clients can access Novotech's unique and unparalleled suite of early to late-phase CRO services across Europe and the US, wit...

January 12, 2023 | News

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversi...

January 12, 2023 | News

Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program

Avance Clinical made the announcement at Biotech Showcase 2023 where the team is taking meetings via PartnershipOne. "Given this successful early adoption ...

January 11, 2023 | News

Aurisco cooperates with Cytiva to build its first Oligo FlexFactory for commercial production

Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year. ...

January 06, 2023 | News

Data Shows 50% of New Trials Have Sites in Asia Pacific

According to the new publication titled "State of the Global Biotech Landscape: Where the Opportunities Lie", demand for Asia Pacific trial sites is strong...

December 15, 2022 | News

Emmes (Global CRO) rapidly expands in India

Global CRO’s India office reports surging growth from Western, regional and local trial customers Emmes – a global, full-se...

October 28, 2022 | News

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...

October 12, 2022 | News

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™

Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...

September 30, 2022 | News

Redbud raises $10M in series A round as CRO focusing on science-driven clinical development

Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...

September 13, 2022 | News

WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility

WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...

September 12, 2022 | News

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...

September 05, 2022 | News

Viva Biotech Announced 2022 Interim Results

Financial Highlights for the 6 months ended June 30, 2022: Revenue amounted to RMB1,108.7 million, representing a year-on-year ("YoY") increas...

August 30, 2022 | News

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...

July 14, 2022 | News

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it...

May 20, 2022 | News

Stay Connected